Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

HP-228 reduces obesity and insulin resistance in animal models

April 23, 1999

Avandia approved in Mexico, approval recommended in U.S.

April 23, 1999

Novel cytotoxic agent from Nippon Steel with potential in inflammation and osteoporosis

April 22, 1999

Abarelix depot is safe and effective in patients with endometriosis

April 22, 1999

Novavax estrogen cream completes phase II trial

April 22, 1999

Hemosol's oxygen carrier cleared for phase III trials in Canada

April 21, 1999

Novel microbial metabolites activate glucokinase activity

April 21, 1999

Vivus receives patent protection for female sexual dysfunction therapy

April 21, 1999

CardioRex versus probucol in atherosclerosis model

April 19, 1999

Hericenal C: new enzyme inhibitor for diabetes mellitus

April 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...